BRIEF-Corbus Pharmaceuticals Initiates "Resolve-1" Phase 3 Study In Systemic Sclerosis

Dec 14 (Reuters) - Corbus Pharmaceuticals Holdings Inc :

* CORBUS PHARMACEUTICALS INITIATES "RESOLVE-1" PHASE 3 STUDY IN SYSTEMIC SCLEROSIS

* CORBUS PHARMA - "EXPECT TO CONCLUDE DOSING IN PHASE 3 STUDY BY END OF 2019, POTENTIALLY POSITIONING CORBUS FOR NDA FILING BY MID-2020" Source text for Eikon: Further company coverage:

See Also: